Designating English as the Official Language of the United States Could Impact Millions with Limited English Proficiency
This issue brief provides an overview of Executive Order (EO) 14224 designating English as the…
Designating English as the Official Language of the United States Could Impact Millions with Limited English Proficiency
This issue brief provides an overview of Executive Order (EO) 14224 designating English as the official language of the United States and its potential implications for multilingual resources, including data on the shares of individuals with LEP across different socioeconomic characteristics based on KFF analysis of 2023 American Community Survey (ACS) data.
Boosting Patient/Member Engagement For Value-based Performance: Why Leaning Into Technology Matters More Than Ever
As healthcare embraces value-based care, data-driven, targeted patient outreach helps close gaps in care that impact performance. The post Boosting Patient/Member Engagement For Value-based Performance: Why Leaning Into Technology Matters More Than Ever appeared first on MedCity News.
Trump Called Digital Equity Act ‘Racist.’ Now Internet Money for Rural Americans Is Gone.
Megan Waiters can recite the stories of dozens of people she has helped connect to the internet in western Alabama. A 7-year-old who couldn’t do classwork online without a tablet, and the 91-year-old she taught to check health care portals on a smartphone. “They have health care needs, but they don’t have the digital skills,”…
Cops on Ketamine? Largely Unregulated Mental Health Treatment Faces Hurdles
If you or someone you know may be experiencing a mental health crisis, contact the 988 Suicide & Crisis Lifeline by dialing or texting “988.” ASHEVILLE, N.C. — A few months ago, Waynesville Police Sgt. Paige Shell was about to give up hope of getting better. The daily drip of violence, death, and misery from…
DUOS Snags $130M to Advance AI, Grow Payer Partnerships
DUOS’ $130 million raise was led by FTV Capital and included participation from Forerunner Ventures. The post DUOS Snags $130M to Advance AI, Grow Payer Partnerships appeared first on MedCity News.
How Much do People with Employer Plans Spend Out-of-Pocket on Cost-Sharing??
This Peterson-KFF Health System Tracker chart collection examines trends in employee spending on deductibles, copayments, and coinsurance from 2012 to 2023 using a sample of health benefit claims for individuals under 65.
KFF Health News’ ‘What the Health?’: Starting To Feel the Shutdown’s Bite
The Host Julie Rovner KFF Health News @jrovner @julierovner.bsky.social Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A…
KFF Health News’ ‘What the Health?’: Starting To Feel the Shutdown’s Bite
The Host Julie Rovner KFF Health News @jrovner @julierovner.bsky.social Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A…
With $4.7B Akero Acquisition, Novo Nordisk Maps Out Broader Strategy in MASH and Beyond
Novo Nordisk is acquiring Akero Therapeutics for drug candidate efruxifermin, which executive say could be first and best in the emerging class of FGF21 analogs for the fatty liver disease MASH. The deal comes months after Novo’s internal FGF21 drug candidate failed a Phase 2 trial. The post With $4.7B Akero Acquisition, Novo Nordisk Maps…
With $4.7B Akero Acquisition, Novo Nordisk Maps Out Broader Strategy in MASH and Beyond
Novo Nordisk is acquiring Akero Therapeutics for drug candidate efruxifermin, which executive say could be first and best in the emerging class of FGF21 analogs for the fatty liver disease MASH. The deal comes months after Novo’s internal FGF21 drug candidate failed a Phase 2 trial. The post With $4.7B Akero Acquisition, Novo Nordisk Maps…
